Hormone Replacement Therapy Market Growth, Size, Trends, Revenue, Share and Future Outlook
Hormone Replacement Therapy Market Size- By Therapy Type, By Route of Administration, By Indication, By Distribution Channel, By End Use- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
| Published: Nov-2023 | Report ID: HLCA2370 | Pages: 1 - 234 | Formats*: |
| Category : Healthcare | |||
Hormone Replacement Therapy Market Introduction and Overview
According to SPER Market Research, the Global Hormone Replacement Therapy Market is estimated to reach USD 63.47 billion by 2033 with a CAGR of 5.32%.
The report includes an in-depth analysis of the Global Hormone Replacement Therapy Market, including market size and trends, product mix, Applications, and supplier analysis. Hormone replacement therapy (HRT) is the use of hormones to replace natural hormones when the body's production is insufficient. Thyroid and human growth hormone patients, for example, might be offered hormone replacement treatment. Furthermore, HRT was often administered to menopausal women to relieve symptoms such as hot flushes, night sweats, sleep disturbances, psychological & Genito-urinary disorders (urinary frequency and vaginal dryness), and to prevent osteoporosis. While HRT can provide significant relief and improve quality of life for people suffering from hormone imbalances, it is not without dangers and should be carefully reviewed and managed by a healthcare practitioner.
- 2022: Ascendis Pharma A/S has acquired European Commission approval to sell its medication SKYTROFA for the treatment of growth hormone abnormalities in children and adolescents.
- 2021: Theramex has announced the clearance of Bijuva / Bijuve throughout Europe and the United Kingdom. Bijuva is a body-identical hormone therapy (HRT) treatment for oestrogen insufficiency symptoms in postmenopausal women with an intact uterus and at least 12 months since last menstruation that contains oestradiol and progesterone in a single daily oral capsule.
- 2020: The US Food and Drug Administration approved Myovant Sciences' Orgovyx (relugolix), an orally administered treatment that works by preventing the pituitary gland from producing luteinizing hormone and follicle-stimulating hormone, resulting in a decrease in the amount of testosterone produced by the testicles. This helps to treat adult patients with advanced prostate cancer.
Market Opportunities and Challenges
The rise in the frequency of menopausal problem and increased mindfulness about post-menopausal enterprises among women are two main reasons driving the growth of the global hormone replacement treatment request. Likewise, new hormone replacement treatment launches are likely to significantly contribute to the growth of the hormone relief replacement request. The arrival of bioidentical hormone replacement treatment and the use of telemedicine for hormone replacement remedy are projected to produce an economic occasion for the worldwide hormone replacement remedy request to expand in the near future. Rising mindfulness about Medicinals, as well as studies being accepted by the government and marketable companies for development in detecting the dangerous factors for the body, are anticipated to fuel request expansion.
Still, multitudinous specialized and functional obstacles, similar as Hormone replacement remedy is associated with a high threat of problems. Post-therapy complications include sleep apnea, acne or other skin responses, bone growth, an increased threat of blood clots, and numerous others. As a result, request expansion is hampered. The high cost of these drugs will really limit request growth.
Market Competitive Landscape
The global hormone replacement treatment industry is highly competitive, and major competitors have used a variety of techniques to gain the most market share. Collaboration, product launch, partnership, and acquisition are among the strategies. To meet the increased need for hormone replacement therapy products, key corporations are launching strategic initiatives. The major players in the market include: Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Hisamitsu Pharmaceutical Co., Inc., Noven Pharmaceuticals, Inc., Merck KGA, Mylan N.V., Novartis International AG, Novo Nordisk A/S, and Pfizer Inc.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | By Therapy Type, By Route of Administration, By Indication, By Distribution Channel, By End Use |
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe |
| Companies Covered | Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Hisamitsu Pharmaceutical Co., Inc., Noven Pharmaceuticals, Inc., Merck KGA, Mylan N.V., Novartis International AG, Novo Nordisk A/S, and Pfizer Inc. |
COVID-19 Impact on Global Hormone Replacement Therapy Market
Throughout the protuberance period, Covid 19 had a significant impact on the hormone replacement therapy assiduity. The transition of healthcare structure to manage COVID- 19 has redounded in drug launch cancellations and clinical trial detainments. Cases with COVID- 19 who had abnormal hormone attention during hospitalisation were set up to have an advanced threat of complaint inflexibility and inflammation in both men and women. According to exploration, COVID- 19 enhances the need for hormone treatment and will accelerate request expansion. Whereas many other studies have indicated that the remedy be halted during COVID- 19, potentially affecting request growth.
Key Target Audience:
- Andropause Men
- Menopausal Women
- Patients with Hormonal Disorder
Our in-depth analysis of the Hormone Replacement Therapy Market includes the following segments:
| By Therapy Type: |
|
| By Route of Administration: |
|
| By Indication: |
|
| By Distribution Channel: |
|
| By End Use: |
|
Key Topics Covered in the Report:
- Global Hormone Replacement Therapy Market Size (FY’2023-FY’2033)
- Overview of Global Hormone Replacement Therapy Market
- Segmentation of Global Hormone Replacement Therapy Market By Therapy Type (Estrogen hormone replacement therapy Filtration, Human growth hormone replacement therapy Pipes, Progestogen hormone replacement therapy, Testosterone hormone replacement therapy, Thyroid hormone replacement therapy)
- Segmentation of Global Hormone Replacement Therapy Market By Route of Administration (Oral, Parenteral, Others)
- Segmentation of Global Hormone Replacement Therapy Market By Indication (Growth hormone deficiency, Hypothyroidism, Male hypogonadism, Menopause, Others)
- Segmentation of Global Hormone Replacement Therapy Market By Distribution Channel (Hospital Pharmacies, Online Pharmacy, Retail Pharmacy)
- Segmentation of Global Hormone Replacement Therapy Market By End Use (Hospitals, Homecare, Speciality Clinics, Others)
- Statistical Snap of Global Hormone Replacement Therapy Market
- Expansion Analysis of Global Hormone Replacement Therapy Market
- Problems and Obstacles in Global Hormone Replacement Therapy Market
- Competitive Landscape in the Global Hormone Replacement Therapy Market
- Impact of COVID-19 and Demonetization on Global Hormone Replacement Therapy Market
- Details on Current Investment in Global Hormone Replacement Therapy Market
- Competitive Analysis of Global Hormone Replacement Therapy Market
- Prominent Players in the Global Hormone Replacement Therapy Market
- SWOT Analysis of Global Hormone Replacement Therapy Market
- Global Hormone Replacement Therapy Market Future Outlook and Projections (FY’2023-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPER’s internal database2.1.4. Premium insight from KOL’s2.2. Market size estimation2.2.1. Top-down and Bottom-up approach2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges4.2. COVID-19 Impacts of the Global Hormone Replacement Therapy Market
5. Market variable and outlook
5.1. SWOT Analysis5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats5.2. PESTEL Analysis5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape5.3. PORTER’s Five Forces5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Hormone Replacement Therapy Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Hormone Replacement Therapy Market
7. Global Hormone Replacement Therapy Market, By Therapy Type (USD Million)
7.1. Global Hormone Replacement Therapy Market Value Share and Forecast, By Therapy Type, 2023-20337.2. Estrogen hormone replacement therapy Filtration7.3. Human growth hormone replacement therapy Pipes7.4. Progestogen hormone replacement therapy7.5. Testosterone hormone replacement therapy7.6. Thyroid hormone replacement therapy
8. Global Hormone Replacement Therapy Market, By Route of Administration (USD Million)
8.1. Global Hormone Replacement Therapy Market Value Share and Forecast, By Route of Administration, 2023-20338.2. Oral8.3. Parenteral8.4. Others
9. Global Hormone Replacement Therapy Market, By Indication (USD Million)
9.1. Global Hormone Replacement Therapy Market Value Share and Forecast, By Indication, 2023-20339.2. Growth hormone deficiency9.3. Hypothyroidism9.4. Male hypogonadism9.5. Menopause9.6. Others
10. Global Hormone Replacement Therapy Market, By Distribution Channel (USD Million)
10.1. Global Hormone Replacement Therapy Market Value Share and Forecast, By Distribution Channel, 2023-203310.2. Hospital Pharmacies10.3. Online Pharmacy10.4. Retail Pharmacy
11. Global Hormone Replacement Therapy Market, By End Use (USD Million)
11.1. Global Hormone Replacement Therapy Market Value Share and Forecast, By End Use, 2023-203311.2. Homecare11.3. Hospitals11.4. Speciality Clinics11.5. Others
12. Global Hormone Replacement Therapy Market Forecast, 2019-2033 (USD Million)
12.1. Global Hormone Replacement Therapy Market Size and Market Share
13. Global Hormone Replacement Therapy Market, By Therapy Type, 2019-2033 (USD Million)
13.1. Global Hormone Replacement Therapy Market Size and Market Share By Therapy Type (2019-2026)13.2. Global Hormone Replacement Therapy Market Size and Market Share By Therapy Type (2027-2033)
14. Global Hormone Replacement Therapy Market, By Route of Administration, 2019-2033 (USD Million)
14.1. Global Hormone Replacement Therapy Market Size and Market Share By Route of Administration (2019-2026)14.2. Global Hormone Replacement Therapy Market Size and Market Share By Route of Administration (2027-2033)
15. Global Hormone Replacement Therapy Market, By Indication, 2019-2033 (USD Million)
15.1. Global Hormone Replacement Therapy Market Size and Market Share By Indication, (2019-2026)15.2. Global Hormone Replacement Therapy Market Size and Market Share By Indication, (2027-2033)
16. Global Hormone Replacement Therapy Market, By Distribution Channel, 2019-2033 (USD Million)
16.1. Global Hormone Replacement Therapy Market Size and Market Share By Distribution Channel, (2019-2026)16.2. Global Hormone Replacement Therapy Market Size and Market Share By Distribution Channel, (2027-2033)
17. Global Hormone Replacement Therapy Market, By End Use, 2019-2033 (USD Million)
17.1. Global Hormone Replacement Therapy Market Size and Market Share By End Use (2019-2026)17.2. Global Hormone Replacement Therapy Market Size and Market Share By End Use (2027-2033)
18. Global Hormone Replacement Therapy Market, By Region, 2019-2033 (USD Million)
18.1. Global Hormone Replacement Therapy Market Size and Market Share By Region (2019-2026)18.2. Global Hormone Replacement Therapy Market Size and Market Share By Region (2027-2033)18.3. Asia-Pacific18.3.1. Australia18.3.2. China18.3.3. India18.3.4. Japan18.3.5. South Korea18.3.6. Rest of Asia-Pacific18.4. Europe18.4.1. France18.4.2. Germany18.4.3. Italy18.4.4. Spain18.4.5. United Kingdom18.4.6. Rest of Europe18.5. Middle East and Africa18.5.1. Kingdom of Saudi Arabia18.5.2. United Arab Emirates18.5.3. Rest of Middle East & Africa18.6. North America18.6.1. Canada18.6.2. Mexico18.6.3. United States18.7. Latin America18.7.1. Argentina18.7.2. Brazil18.7.3. Rest of Latin America
19. Company Profile
19.1. Abbott Laboratories19.1.1. Company details19.1.2. Financial outlook19.1.3. Product summary19.1.4. Recent developments19.2. Bayer AG19.2.1. Company details19.2.2. Financial outlook19.2.3. Product summary19.2.4. Recent developments19.3. Eli Lilly and Company19.3.1. Company details19.3.2. Financial outlook19.3.3. Product summary19.3.4. Recent developments19.4. F. Hoffmann-La Roche Ltd.19.4.1. Company details19.4.2. Financial outlook19.4.3. Product summary19.4.4. Recent developments19.5. Hisamitsu Pharmaceutical Co. Inc.19.5.1. Company details19.5.2. Financial outlook19.5.3. Product summary19.5.4. Recent developments19.6. Merck KGA19.6.1. Company details19.6.2. Financial outlook19.6.3. Product summary19.6.4. Recent developments19.7. Mylan N.V.19.7.1. Company details19.7.2. Financial outlook19.7.3. Product summary19.7.4. Recent developments19.8. Novartis International AG19.8.1. Company details19.8.2. Financial outlook19.8.3. Product summary19.8.4. Recent developments19.9. Noven Pharmaceuticals, Inc.19.9.1. Company details19.9.2. Financial outlook19.9.3. Product summary19.9.4. Recent developments19.10. Novo Nordisk A/S19.10.1. Company details19.10.2. Financial outlook19.10.3. Product summary19.10.4. Recent developments19.11. Pfizer Inc19.11.1. Company details19.11.2. Financial outlook19.11.3. Product summary19.12. Others
20. List of Abbreviations
21. Reference Links
22. Conclusion
23. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Hormone Replacement Therapy Market is projected to reach USD 63.47 billion by 2033, growing at a CAGR of 5.32% during the forecast period.
Hormone Replacement Therapy Market grew in market size from 2023. The Market is expected to reach USD 63.47 billion by 2033, at a CAGR of 5.32% during the forecast period.
Hormone Replacement Therapy Market CAGR of 5.32% during the forecast period.
"You can get the sample pages by clicking the link -Click Here"
Hormone Replacement Therapy Market size is USD 63.47 billion from 2023 to 2033.
Hormone Replacement Therapy Market Segment is Covered By Therapy Type, By Route of Administration, By Indication, By Distribution Channel, By End Use
The North America region is anticipated to have the highest market share in Hormone Replacement Therapy Market.
The key players in the market include Companies Covered Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Hisamitsu Pharmaceutical Co., Inc., Noven Pharmaceuticals, Inc., Merck KGA, Mylan N.V., Novartis International AG, Novo Nordisk A/S, and Pfizer Inc.
Thyroid and human growth hormone patients, for example, might be offered hormone replacement treatment. Furthermore, HRT was often administered to menopausal women to relieve symptoms such as hot flushes, night sweats, sleep disturbances, psychological & Genito-urinary disorders (urinary frequency and vaginal dryness), and to prevent osteoporosis.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
